Filing Details
- Accession Number:
- 0000939767-19-000111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-03 20:52:48
- Reporting Period:
- 2019-05-01
- Accepted Time:
- 2019-05-03 20:52:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
939767 | Exelixis Inc. | EXEL | Services-Commercial Physical & Biological Research (8731) | 043257395 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1202102 | A George Scangos | C/O Exelixis, Inc. 1851 Harbor Bay Parkway Alameda CA 94502 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-05-01 | 25,000 | $19.75 | 1,248,031 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-05-02 | 15,000 | $20.00 | 1,233,031 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 8,963 | Indirect | By Trust (JS) |
Common Stock | 8,963 | Indirect | By Trust (KS) |
Common Stock | 5,669 | Indirect | By 401(k) Plan |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018.
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.60 to $19.84. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
- Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Jennifer Scangos Trust.
- Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Katherine Scangos Trust.
- Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 1, 2019.